
Rilshield
Rilshield® is a brand of Rilpivirine, a high potency second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of HIV/AIDS. It is recommended for patients with a viral load of 100,000 copies/mL or less at the beginning of therapy.